Sol-Gel Technologies (SLGL) Shareholder's Equity Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Sol-Gel Technologies | 205.76 Mn | 194.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.93% |
| Sep 30, 2025 | -25.00% |
| Jun 30, 2025 | -8.65% |
| Mar 31, 2025 | -38.22% |
| Dec 31, 2024 | -25.34% |
| Sep 30, 2024 | -19.53% |
| Jun 30, 2024 | -27.73% |
| Mar 31, 2024 | -25.90% |
| Dec 31, 2023 | -8.45% |
| Sep 30, 2023 | -9.16% |
| Jun 30, 2023 | -4.08% |
| Mar 31, 2023 | -12.09% |
| Dec 31, 2022 | -24.07% |
| Sep 30, 2022 | 14.55% |
| Jun 30, 2022 | 28.29% |
| Mar 31, 2022 | 6.51% |
| Dec 31, 2021 | 9.33% |
| Sep 30, 2021 | -27.49% |
| Jun 30, 2021 | -40.10% |
| Mar 31, 2021 | -29.90% |
| Dec 31, 2020 | -3.08% |
| Sep 30, 2020 | -2.41% |
| Jun 30, 2020 | 19.69% |
| Mar 31, 2020 | 13.84% |
| Dec 31, 2019 | -17.91% |
| Dec 31, 2018 | 221.27% |
| Dec 31, 2017 | -68.17% |